Abstract
Recombinant human collagen (rhCol) holds broad potential in biomedical and industrial applications due to its high purity and low immunogenicity. However,
Funding Information
  • the Natural Science Foundation of Shandong province (ZR201911180224)
  • the Natural Science Foundation of Shandong province (ZR201911180224)
  • the Natural Science Foundation of Shandong province (ZR201911180224)
  • the Natural Science Foundation of Shandong province (ZR201911180224)
  • the Natural Science Foundation of Shandong province (ZR201911180224)
  • the Natural Science Foundation of Shandong province (ZR201911180224)
  • the Natural Science Foundation of Shandong province (ZR201911180224)
  • the Natural Science Foundation of Shandong province (ZR201911180224)
  • This study was supported by the National Natural Science Foundation of China (No. 32001836)
  • This study was supported by the National Natural Science Foundation of China (No. 32001836)
  • This study was supported by the National Natural Science Foundation of China (No. 32001836)
  • This study was supported by the National Natural Science Foundation of China (No. 32001836)
  • This study was supported by the National Natural Science Foundation of China (No. 32001836)
  • This study was supported by the National Natural Science Foundation of China (No. 32001836)
  • This study was supported by the National Natural Science Foundation of China (No. 32001836)
  • This study was supported by the National Natural Science Foundation of China (No. 32001836)

This publication has 52 references indexed in Scilit: